Evogene Ltd. (EVGN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Evogene Ltd.

    NASDAQ: EVGN · Real-Time Price · USD
    1.24
    -0.04 (-3.35%)
    At close: Sep 11, 2025, 3:59 PM
    1.26
    1.61%
    After-hours: Sep 11, 2025, 05:29 PM EDT

    Evogene Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 8.51M 5.64M 1.68M 930K
    Cost of Revenue
    		 2.68M 4.24M 909K 767K
    Gross Profit
    		 5.83M 1.4M 766K 163K
    Operating Income
    		 -22.21M -26.39M -26.94M -30.95M
    Interest Income
    		 957K 1.25M 516K 1.94M
    Pretax Income
    		 -18.05M -25.99M -29.75M -30.43M
    Net Income
    		 -16.48M -23.88M -26.64M -27.79M
    Selling & General & Admin
    		 10.87M 9.68M 10.41M 7.25M
    Research & Development
    		 16.65M 18.11M 20.79M 23.86M
    Other Expenses
    		 524K n/a -3.5M n/a
    Operating Expenses
    		 28.04M 27.79M 27.71M 31.12M
    Interest Expense
    		 124K 171K 3.33M 1.41M
    Selling & Marketing Expenses
    		 822K 1.01M 3.93M n/a
    Cost & Expenses
    		 30.72M 32.03M 28.62M 31.88M
    Income Tax Expense
    		 9K -33K 90K 13K
    Shares Outstanding (Basic)
    		 5.7M 4.57M 4.12M 41.01M
    Shares Outstanding (Diluted)
    		 5.7M 4.57M 4.12M 41.01M
    EPS (Basic)
    		 -2.89 -5.23 -6.46 -0.68
    EPS (Diluted)
    		 -2.89 -5.23 -6.46 -0.68
    EBITDA
    		 -15.48M -23.2M -26.93M -27.8M
    EBIT
    		 -17.98M -25.87M -29.59M -30.03M
    Depreciation & Amortization
    		 2.5M 2.61M 2.58M 2.23M

    Add to Watchlist